PDCD1 and type 1 diabetes mellitus: Besides the observation of immune cell infiltrates, GAD-reactive T cells, and high glucose levels, we describe, to our knowledge for the first time, longitudinal changes in the gut microbiota following anti–PD-1 treatment by identifying bacterial species as early markers before T1D onset.